AdaptHealth (AHCO) EBITDA Margin (2019 - 2026)

AdaptHealth (AHCO) recorded quarterly EBITDA Margin of 13.06% in Q1 2026, up 475.15% quarter-over-quarter from 2.27% in Q4 2025, and down 138.0% on a YoY basis from 34.38% in Q1 2025.

AdaptHealth (AHCO) EBITDA Margin (2019 - 2026) Analysis & Trends

AdaptHealth's EBITDA Margin history runs 8 years deep, the most recent figure standing at 13.06% for Q1 2026.

  • In Q1 2026, EBITDA Margin fell 138.0% year-over-year to 13.06%; the TTM figure through Mar 2026 stood at 13.6% (down 431.0% YoY), while the FY2025 annual figure was 13.94%, down 466.0% from the prior year.
  • EBITDA Margin was 13.06% for Q1 2026 at AdaptHealth, up from 2.27% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 21.32% in Q4 2024 to a low of 46.11% in Q3 2023.
  • Historically, EBITDA Margin has averaged 10.75% across 5 years, with a median of 17.08% in 2024.
  • The sharpest annual moves came in 2023 and 2024: EBITDA Margin tumbled 6400 bps in 2023, then jumped 6456 bps in 2024.
  • A 5-year view of EBITDA Margin shows it stood at 15.25% in 2022, then sank by 200 bps to 15.26% in 2023, then jumped by 240 bps to 21.32% in 2024, then sank by 89 bps to 2.27% in 2025, then soared by 475 bps to 13.06% in 2026.
  • The last three EBITDA Margin figures came in at 13.06% (Q1 2026), 2.27% (Q4 2025), and 18.81% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 12.05%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 15.55%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 16.24%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.04%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 19.94%
10 AdaptHealth 1.30 Bn 1.26 Bn 111.50 Mn 13.06%

Historic Data

Download Data
DateValue
Mar 31, 2026 13.06%
Dec 31, 2025 2.27%
Sep 30, 2025 18.81%
Jun 30, 2025 20.80%
Mar 31, 2025 14.45%
Dec 31, 2024 21.32%
Sep 30, 2024 18.45%
Jun 30, 2024 17.08%
Mar 31, 2024 17.39%
Dec 31, 2023 -15.26%
Sep 30, 2023 -46.11%
Jun 30, 2023 18.10%
Mar 31, 2023 14.77%
Dec 31, 2022 15.25%
Sep 30, 2022 17.89%
Jun 30, 2022 17.67%
Mar 31, 2022 16.80%
Dec 31, 2021 19.10%
Sep 30, 2021 20.73%
Jun 30, 2021 18.69%